Funded Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Initiative	Program Official
Abrams, Julian	Columbia University Health Sciences United States	The Oral Microbiome for the Detection of Barretts Esophagus	5R01CA238433-05
Abyzov, Alexej	Mayo Clinic Rochester United States	Detection of somatic, subclonal and mosaic CNVs from sequencing	5U24CA220242-05		Christos Patriotis, Ph.D., M.Sc.
Acciavatti, Raymond Joseph	University Of Pennsylvania United States	Next-Generation Tomosynthesis Pilot Study	5R37CA273959-02
Acharya, Munjal M	University Of California-Irvine United States	Stem cell-derived exosomes to ameliorate chemobrain	5R01CA262213-02		Rachel Altshuler, Ph.D.
Adams-Campbell, Lucile Lauren	Georgetown University United States	National Capital Area (NCA) Minority/Underserved NCORP	5UG1CA239758-05
Adebamowo, Clement Adebayo	University Of Maryland Baltimore United States	Baltimore CASCADE Study Site (BaCSS Project)	1UG1CA284883-01		Silvina Frech, Ph.D., M.S.
Afshar-Kharghan, Vahid	University Of Tx Md Anderson Can Ctr United States	Novel Biomarkers Predicting Blood Clots in Ovarian Cancer	1R01CA275762-01A1		Rachel Altshuler, Ph.D.
Agarwal, Ashutosh	University Of Miami School Of Medicine United States	A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer	5U01CA233363-05
Agarwal, Rajesh	University Of Colorado Denver United States	Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy	3R01CA140368-10S1	PA-20-227 (Admin Supp-Clinical Trial Not Allowed)	Amit Kumar, Ph.D.
Agsalda-Garcia, Melissa Anne	University Of Hawaii At Manoa United States	Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients	1R21CA244078-01	PAR-18-020 (R21 Clinical Trial Optional)	Guillermo Marquez, Ph.D.
Ah, Diane Marie Von	Ohio State University United States	Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial	5R01CA276222-02
Ahn, Jiyoung	New York University School Of Medicine United States	The Oral Mycobiome and Risk of Pancreatic Cancer	5U01CA250186-03	PAR-18-913 (U01 Clinical Trial Not Allowed)
Alambeigi, Farshid	University Of Texas At Austin United States	A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps	1R21CA280747-01A1		Matthew Young, Ph.D.
Albertson, Donna G	New York University United States	Artemin overexpression in oral cancer pain and carcinogenesis	5R01CA228525-05		Rachel Altshuler, Ph.D.
Alexandrov, Ludmil B	University Of California, San Diego United States	Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition	1U01CA290479-01		Wendy Wang, Ph.D., M.Sc.
Allen, Peter J	Duke University United States	Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)	5R01CA235677-05
Allen, Peter J	Duke University United States	Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas	2R01CA182076-06A1
Altorki, Nasser Khaled	Weill Medical Coll Of Cornell Univ United States	Intercepting progression from pre-invasive to invasive lung adenocarcinoma	3UH3CA244697-05S1
Ameringer, Suzanne W	Virginia Commonwealth University United States	A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer	1R01CA286799-01		Ellen Richmond, M.S., G.N.P.-B.C.
Anderson, Karen S.	Arizona State University-Tempe Campus United States	Rapid Point of Care Detection of HPV-Associated Malignancies	5UH3CA211415-06		Christos Patriotis, Ph.D., M.Sc.
Anderson, Karen S.	Arizona State University-Tempe Campus United States	Southwest EDRN Clinical Validation Center for Head and Neck Cancer	1U01CA281660-01		Wendy Wang, Ph.D., M.Sc.
Anderson, Daniel M	Healthpartners Institute United States	Metro-Minnesota Community Oncology Research Consortium (MMCORC)	5UG1CA189863-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Anderson, Garnet L.	Fred Hutchinson Cancer Center United States	NCI Cancer Screening Research Network: Coordinating and Communication Center	1UG1CA286954-01		Elyse LeeVan, M.D., M.P.H.
Arcaro, Kathleen Frances	University Of Massachusetts Amherst United States	Fruit and vegetable intervention in lactating women to reduce breast cancer risk: effects on breast cell DNA methylation, breast inflammation, and weight	5R01CA230478-05
Armstrong, Gregory	St. Jude Children'S Research Hospital United States	Sen-Survivors: An open-label intervention trial for frailty and senescence	1U01CA246510-01		Eileen Dimond, R.N., M.S.
Arnold, Corey Wells	University Of California Los Angeles United States	Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification	1R01CA279666-01A1		Indu Kohaar, Ph.D.
Atigadda, Venkatram Reddy	University Of Alabama At Birmingham United States	Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer	5R01CA276683-02
Augenlicht, Leonard H	Albert Einstein College Of Medicine United States	A Major Nutritional Effect on Intestinal Stem Cells and Tumors	5R01CA214625-06		Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Augenlicht, Leonard H	Albert Einstein College Of Medicine United States	Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis	5R01CA222358-06		Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Augenlicht, Leonard H	Albert Einstein College Of Medicine United States	Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells	5R01CA229216-06		Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Azizoddin, Desiree R	University Of Oklahoma Hlth Sciences Ctr United States	Leveraging mHealth to deliver integrated pain-CBT, opioid monitoring, and self-management support for advanced cancer patients coping with chronic pain	5R21CA263838-02
Badu-Tawiah, Abraham	Ohio State University United States	Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening	5R21CA270727-02	PAR-20-292 (R21 Clinical Trial Optional)
Badve, Sunil S.	Emory University United States	Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms	1R01CA281932-01A1
Bae-Jump, Victoria Lin	Univ Of North Carolina Chapel Hill United States	Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer	5R37CA226969-07
Baghdadi, Tareq Al	Saint Joseph Mercy Health System United States	Michigan Cancer Research Consortium NCORP	5UG1CA189971-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Bailey, Lisa (Nmn)	Bay Area Tumor Institute United States	Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites	5UG1CA189817-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Balmain, Allan	University Of California, San Francisco United States	PROMINENT - UCSF	3OT2CA278665-01S1
Balu, Mihaela	University Of California-Irvine United States	Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma	5R01CA259019-02	PAR-20-155 (R01 Clinical Trial Optional)
Bao, Ting	Dana-Farber Cancer Inst United States	Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial	5R01CA251470-05
Bao, Ting	Dana-Farber Cancer Inst United States	Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial	7R37CA248563-04
Barber, Glen N.	University Of Miami School Of Medicine United States	Development of A HTLV-1 Vaccine	5R01CA252049-04	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Barroilhet, Lisa M	University Of Wisconsin-Madison United States	The MW Cancer Prevention Clinical Trials Network	5UG1CA242635-04		Donald Johnsey
Barroilhet, Lisa M	University Of Wisconsin-Madison United States	Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation	3R01CA238423-04S1
Barton, Jennifer Kehlet	University Of Arizona United States	Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers	3R01CA260399-03S1
Basch, Ethan M.	Univ Of North Carolina Chapel Hill United States	Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability	3U01CA233046-05S1		Rachel Altshuler, Ph.D.
Bast, Robert C	University Of Tx Md Anderson Can Ctr United States	MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm	2U01CA200462-06A1
Basu, Partha	International Agency For Res On Cancer United States	A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs	1R37CA275824-01		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Bea, Jennifer Wright	University Of Arizona United States	Adipose and Lean Soft Tissue Depots, Cancer Risk and Mortality in Postmenopausal Women	3R01CA253302-03S1		Edward Sauter, M.D., Ph.D.
Beane, Jennifer Ellen	Boston University Medical Campus United States	PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learning	1R21CA253498-01		Guillermo Marquez, Ph.D.
Berenberg, Jeffrey Lee	University Of Hawaii At Manoa United States	The Hawaii Minority/Underserved NCORP	5UG1CA189804-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Beretta, Laura	University Of Tx Md Anderson Can Ctr United States	Early Detection of Hepatocellular Carcinoma	5R01CA195524-08	PAR-19-264 (R01 Clinical Trial Optional)
Bergan, Raymond C	University Of Nebraska Medical Center United States	Preventing invasive prostate cancer	1R01CA276846-01		John Clifford, Ph.D.
Bertozzi, Carolyn	Stanford University United States	Chemical Glycoproteomics	5R01CA200423-20	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Bhatt, Vijaya Raj	University Of Nebraska Medical Center United States	Aging trajectories and outcomes of older adults with acute myeloid leukemia	1R37CA276928-01A1		Brennan Streck, Ph.D., R.N., M.P.H.
Bissonnette, Bruce Marc	University Of Chicago United States	CXCR4 as a target for colon cancer chemoprevention	5R01CA240710-05
Blanke, Charles D.	Oregon Health & Science University United States	Cancer Disparity Collaborative Supplement: Integrating electronic health record and patient-generated health data for breast cancer and cardiovascular disease risk assessment among diverse multiet...	3UG1CA189974-10S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Borges, Chad R	Arizona State University-Tempe Campus United States	Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions	5R21CA269091-02	RFA-CA-21-005 (R21 Clinical Trial Not Allowed)
Boutros, Paul Christopher	University Of California Los Angeles United States	Germline Determinants of Prostate Cancer Evolution	5R01CA270108-02
Boyer, Thomas G	University Of Texas Hlth Science Center United States	Pathological reprogramming of the m6A epitranscriptome in uterine fibroids	5R01HD106285-03
Brand, Randall	University Of Pittsburgh At Pittsburgh United States	Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma	5U01CA200466-07
Brennan, Paul Joseph	International Agency For Res On Cancer United States	PROMINENT - IARC	3OT2CA278681-01S1
Brenner, Dean E.	University Of Michigan At Ann Arbor United States	Early Phase Clinical Cancer Prevention Consortium	5UG1CA242632-04	RFA-CA-19-031 (UG1 Clinical Trial Required)	Donald Johnsey
Bride, Colleen M Mc	Emory University United States	Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic Services	5U01CA240581-04	PAR-18-616 (U01 Clinical Trial Optional)
Brown, Austin L	Baylor College Of Medicine United States	A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia	5R01CA272981-02
Bruner, Deborah Watkins	Nrg Oncology Foundation, Inc. United States	NRG Oncology NCORP Research Base	5UG1CA189867-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Bryan, Angela	University Of Colorado United States	Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC	1R01CA284860-01		Brennan Streck, Ph.D., R.N., M.P.H.
Buchanan, Adam H	Geisinger Clinic United States	Feasibility and Assessment of a Cascade Traceback Screening program - FACTS	5U01CA240747-04	PAR-18-616 (U01 Clinical Trial Optional)
Buczynski, Matthew Wallace	Virginia Polytechnic Inst And St Univ United States	Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy	1R01CA284075-01		Rachel Altshuler, Ph.D.
Bylund, Carma L.	University Of Florida United States	Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators	5R01CA253330-03
Cantuaria, Guilherme	Northside Hospital Atlanta United States	Georgia NCI Community Oncology Research Program (GA NCORP)	5UG1CA189997-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cao, Yin	Washington University United States	Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia	5R37CA246175-04
Cao, Lei	Ohio State University United States	Cancer prevention and treatment by activation of a brain-adipocyte axis	5R01CA166590-10		Winfred Malone, Ph.D., M.P.H.
Carlson, Jay W	Ozark Health Ventures, Llc United States	Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO)	5UG1CA189822-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Carlsson, Sigrid	Sloan-Kettering Inst Can Research United States	Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers	5U01CA266535-02	PAR-18-913 (U01 Clinical Trial Not Allowed)
Carson, Tiffany Lashaun	H. Lee Moffitt Cancer Ctr & Res Inst United States	Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults	5R01CA253219-04
Carter, Bob S	Massachusetts General Hospital United States	Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas	5U01CA230697-05
Carter, Bob S	Massachusetts General Hospital United States	Standardized Molecular Analyses of Glioma EVs	5R01CA237500-04
Castro, Cesar M	Massachusetts General Hospital United States	Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach	1U01CA279858-01		Christos Patriotis, Ph.D., M.Sc.
Caulin, Carlos	University Of Arizona United States	Genetic Alterations That Confer High Risk to Oral Premalignant Lesions	5R01CA274857-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Caywood, Emi H	Alfred I. Du Pont Hosp For Children United States	Nemours NCI Community Oncology Research Program (NCORP)	5UG1CA189958-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Chak, Amitabh	Case Western Reserve University United States	Pathways of Injury and Repair in Barrett's Carcinogenesis	1P01CA269019-01A1		Ellen Richmond, M.S., G.N.P.-B.C.
Chan, Daniel Wanyui	Johns Hopkins University United States	Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions	1U01CA274514-01A1
Chan, Andrew T	Massachusetts General Hospital United States	Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention.	5R01CA257523-03
Chan, Daniel Wanyui	Johns Hopkins University United States	BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs	1U2CCA271895-01A1		Indu Kohaar, Ph.D.
Chan, Alexandre	University Of California-Irvine United States	Neurotrophic strategy to mitigate chemotherapy-related brain injury	1R01CA276212-01A1		Catherine Schweppe, Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	Precision Prevention Research Program	5R35CA253185-04	PAR-19-349 (R35 Clinical Trial Not Allowed)
Chang, Su-Hsin	Washington University United States	Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective	5R01CA253475-03		Asad Umar, D.V.M., Ph.D.
Chapkin, Robert Stephen	Texas A&M Agrilife Research United States	Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling	5R01CA244359-04
Chauhan, Subhash C.	University Of Texas Rio Grande Valley United States	MUC13 Mucin in Colerectal Cancer Health Disparity	5R01CA204552-05		Matthew Young, Ph.D.
Chen, Grace Y.	University Of Michigan At Ann Arbor United States	Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention	5R21CA273646-02
Chen, Ru	Baylor College Of Medicine United States	Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis	5R01CA211892-06		Matthew Young, Ph.D.
Cheng, Leo L	Massachusetts General Hospital United States	Novel metabolomic contrast probes for human lung cancer characterization	5R01CA273010-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Cheville, Andrea Lynne	Mayo Clinic Rochester United States	Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial	4R33CA278594-02		Brennan Streck, Ph.D., R.N., M.P.H.
Chibwesha, Carla J	Univ Of North Carolina Chapel Hill United States	Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV	5R01CA250850-04
Chinnaiyan, Arul M	University Of Michigan At Ann Arbor United States	Michigan-VUMC Biomarker Characterization Center	5U2CCA271854-02
Chirenje, Zvavahera Mike	University Of California, San Francisco United States	Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)	1UG1CA284918-01		Silvina Frech, Ph.D., M.S.
Chow, H-H. Sherry	University Of Arizona United States	University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)	5UG1CA242596-05	RFA-CA-18-029 (UG1 Clinical Trial Required)	Donald Johnsey
Chung, Ki Young	Prisma Health - Upstate United States	NCORP of the Carolinas (Greenville Health System NCORP)	6UG1CA189972-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Chung, Michael Hoonbae	Emory University United States	HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya)	5UG1CA275400-02		Silvina Frech, Ph.D., M.S.
Chung, Raymond T	Massachusetts General Hospital United States	Trial of Statins for Chemoprevention in Hepatocellular Carcinoma	5R01CA255621-03
Chung, Fung-Lung	Georgetown University United States	gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention	5U01CA220477-05		Wendy Wang, Ph.D., M.Sc.
Clapper, Margie L.	Research Inst Of Fox Chase Can Ctr United States	Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center	5U54CA272686-02	RFA-CA-21-038 (U54 Clinical Trial Not Allowed)
Clapper, Margie L.	Research Inst Of Fox Chase Can Ctr United States	Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis	5R01CA262551-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Cocucci, Emanuele	Ohio State University United States	A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL	5R01CA270251-02	PAR-20-053 (R01 Clinical Trial Not Allowed)
Coffey, Robert J.	Vanderbilt University Medical Center United States	Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation	3U2CCA233291-01S2		Richard Mazurchuk, Ph.D.
Cohen, Lorenzo	University Of Tx Md Anderson Can Ctr United States	Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery	1R01CA272565-01A1
Cohn, Barbara A	Public Health Institute United States	Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer	5R01CA264519-03		Howard L. Parnes, M.D.
Cole, Peter D	Rutgers Biomedical And Health Sciences United States	Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL	7R01CA220568-05
Coleman, William B	American Society/Investigative Pathology United States	2024 Annual Meeting of the American Society for Investigative Pathology	1R13CA290991-01
Coleman, William B	American Society/Investigative Pathology United States	2023 Annual Meeting of the American Society for Investigative Pathology	1R13CA284830-01
Conley, Yvette P	University Of Pittsburgh At Pittsburgh United States	Epigenomics of Neurocognitive Function in Breast Cancer	5R01CA221882-05
Cook, Linda S	University Of Colorado Denver United States	Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)	1UG1CA286941-01		Elyse LeeVan, M.D., M.P.H.
Cope, Timothy C	Georgia Institute Of Technology United States	Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy	5R01CA221363-05		Rachel Altshuler, Ph.D.
Counter, Christopher M	Duke University United States	PROMINENT-DUKE	3OT2CA278661-01S1
Counter, Christopher M	Duke University United States	Adapting K-MDS to detect KRAS-mutant ctDNA	5R21CA257816-02
Cremer, Miriam	Cleveland Clinic Lerner Com-Cwru United States	Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador	3R01CA266059-02S1
Crew, Katherine D	Columbia University Health Sciences United States	Multicenter trial of decision support for breast cancer chemoprevention	3R01CA226060-05S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Crott, Jimmy W	Boston University Medical Campus United States	Identifying the active factor of an anti-inflammatory chemopreventive bacterium	7R21CA253392-02		Young Kim, Ph.D.
Curiel-Lewandrowski, Clara	University Of Arizona United States	Targeted Prevention for Non-Melanoma Skin Cancer	5P01CA229112-05	PAR-18-290 (P01 Clinical Trial Optional)
Curtis, Amarinthia E	Spartanburg Regional Medical Center United States	Upstate Carolina Consortium - Community Oncology Research Program	5UG1CA239762-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Curtius, Kathleen M.	University Of California, San Diego United States	Multiscale modeling of spatiotemporal evolution in Barrett's esophagus	1R01CA270235-01A1		Ellen Richmond, M.S., G.N.P.-B.C.
Damaj, M. Imad	Virginia Commonwealth University United States	Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms	5R01CA272147-02
Dandoy, Christopher Eugene	Cincinnati Childrens Hosp Med Ctr United States	The 11th Annual PTCTC Educational Meeting, The First 100 Days After Stem Cell Transplant	1R13HL173950-01
Dantzer, Robert	University Of Tx Md Anderson Can Ctr United States	The Metabolic Basis of Cancer-Related Fatigue	5R01CA193522-09
Darie, Costel C.	Clarkson University United States	PA-21-071 for Pathea Bruno to CA260126-01 Identifying a proteomic signature for breast cancer detection in breast milk and serum	3R15CA260126-01A1S1
Dasgupta, Piyali	Marshall University United States	Capsaicin and small cell lung cancer therapy	2R15CA161491-03		Gabriela Riscuta, M.D., C.N.S.
Dashwood, Roderick H	Texas A&M University Health Science Ctr United States	Immunoepigenetic targeting of MHC regulators in FAP	5R01CA257559-02
Dashwood, Roderick H	Texas A&M University Health Science Ctr United States	CCAR2 as a Target for Prevention of Colorectal Cancer.	5R01CA122959-11
Davis, Jennifer Sarah	University Of Kansas Medical Center United States	Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype	7U01CA222163-04		Claire Zhu, Ph.D.
Degnim, Amy C	Mayo Clinic Rochester United States	Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia	5R01CA237607-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Demehri, Shadmehr	Massachusetts General Hospital United States	Epithelium-derived alarmins role in breast cancer immunoprevention	5U01CA233097-05		Mark Steven Miller, Ph.D.
Deng, Gary E	Sloan-Kettering Inst Can Research United States	Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial	1R21CA286330-01		Goli Samimi, Ph.D., M.P.H.
Deng, Youping	University Of Hawaii At Manoa United States	Profiling genome-wide circulating ncRNAs for the early detection of lung cancer	5R01CA223490-05
Deng, Youping	University Of Hawaii At Manoa United States	Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms	5R01CA230514-05
Dhakal, Soma	Virginia Commonwealth University United States	Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers	5R61CA278445-02
Diaz, Juan Sebastian Gomez	University Of California At Davis United States	A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids	5R01CA273253-02
Digiovanni, John	University Of Texas At Austin United States	Identification of Natural Compound Combinations for Prevention of Prostate Cancer	5R01CA228404-05		Marjorie Perloff, M.D.
Djuric, Zora	University Of Michigan At Ann Arbor United States	MyGI Diet for Colorectal Cancer Prevention	5R01CA255743-03
Doescher, Mark P	University Of Oklahoma Hlth Sciences Ctr United States	Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub	1UG1CA287044-01		Elyse LeeVan, M.D., M.P.H.
Doolittle, Gary C.	University Of Kansas Medical Center United States	The University of Kansas Cancer Center's- MCA Rural NCORP	5UG1CA239767-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Drake, Richard R.	Medical University Of South Carolina United States	Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids	5R33CA267226-03	RFA-CA-21-004 (R33 Clinical Trial Not Allowed)
Drescher, Charles	Swedish Medical Center, First Hill United States	The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site	5UG1CA189953-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Dryden-Peterson, Scott Lee	Brigham And Women'S Hospital United States	A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation	5R01CA236546-05
Dryden-Peterson, Scott Lee	Brigham And Women'S Hospital United States	Botswana CASCADE Clinical Trials Site	5UG1CA275416-02		Silvina Frech, Ph.D., M.S.
Duncavage, Eric J	Washington University United States	Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes	1UH2CA272904-01
Eibl, Guido Erwin Michael	University Of California Los Angeles United States	Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma	5P01CA236585-04	PAR-18-290 (P01 Clinical Trial Optional)
El-Bayoumy, Karam E	Pennsylvania State Univ Hershey Med Ctr United States	Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies	5R01CA173465-10
El-Serag, Hashem B	Baylor College Of Medicine United States	Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome	5P01CA263025-02
Elenitoba-Johnson, Kojo S. J.	Sloan-Kettering Inst Can Research United States	Genomic biomarkers of splenic lymphoma	5R01CA255655-05
Elias, Kevin	Brigham And Women'S Hospital United States	Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness	1R03CA283252-01		Christos Patriotis, Ph.D., M.Sc.
Ellerton, John A	Southern Nevada Cancer Research Fdn United States	NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)	5UG1CA189829-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Enzinger, Andrea C	Dana-Farber Cancer Inst United States	Development of A Mindfulness-Based Mobile Health Intervention for Patients Coping with Pain from Advanced Malignancies	5R21CA270069-02
Esserman, Laura J	University Of California, San Francisco United States	Extending the Diversity, Reach, and Generalizability of the WISDOM Study	5R01CA237533-05
Fabian, Carol J	University Of Kansas Medical Center United States	Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer	5R01CA249437-03		Edward Sauter, M.D., Ph.D.
Fahrmann, Johannes F	University Of Tx Md Anderson Can Ctr United States	Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer	1U01CA282216-01		Claire Zhu, Ph.D.
Faller, Bryan	Decatur Memorial Hospital United States	Heartland Cancer Research NCORP	5UG1CA189830-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Fan, Rong	Yale University United States	Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies	3U01CA260507-02S2
Faris, Gregory W	Numentus Technologies Inc. United States	Decoding Individual Exosomes in Cancer	5R21CA236686-02
Feliciano, Elizabeth Marjorie Cespedes	Kaiser Foundation Research Institute United States	D3-creatine dilution to determine skeletal muscle mass in colon cancer patients	5R01CA240394-04	PAR-18-893 (R01 Clinical Trial Optional)	Gabriela Riscuta, M.D., C.N.S.
Feng, Ziding	Fred Hutchinson Cancer Center United States	Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC)	2U24CA230144-07		Guillermo Marquez, Ph.D.
Feng, Ziding	Fred Hutchinson Cancer Center United States	The Early Detection Research Network: Data Management and Coordinating Center	5U24CA086368-23	RFA-CA-21-034 (U24 Clinical Trial Not Allowed)
Figueiredo, Jane C.	Cedars-Sinai Medical Center United States	Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2	3U54CA260591-02S3
Findlay, Victoria Jane	Virginia Commonwealth University United States	The effects of time restricted feeding on AGE-RAGE signaling in women at high risk for breast cancer	7R21CA258139-02		Edward Sauter, M.D., Ph.D.
Fiol, Guilherme Del	University Of Utah United States	GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management	1U24CA274582-01A1		Christos Patriotis, Ph.D., M.Sc.
Fitzgibbon, Marian L	University Of Illinois At Chicago United States	Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk	5R01CA250390-04
Flory, James H	Sloan-Kettering Inst Can Research United States	Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life	1R21CA277464-01A1		Sharon Ross, Ph.D., M.P.H.
Flowers, Lisa C.	Emory University United States	Screening strategies and social determinants of health among people with high risk of anal cancer	1R01CA285198-01		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Flowers, Lisa C.	Emory University United States	Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)	1UG1CA284884-01		Silvina Frech, Ph.D., M.S.
Forsberg, Flemming	Thomas Jefferson University United States	Prostate Cancer Diagnosis by Multiparametric Ultrasound	5R01CA252311-04
Fortier, Michelle	University Of California-Irvine United States	Innovative Pain and Symptom Management Program for Children with Cancer	3R01CA222012-05S1
Frazier, A Lindsay	Dana-Farber Cancer Inst United States	Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors	5UH3CA240688-04
Freedland, Stephen Jay	Cedars-Sinai Medical Center United States	Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes	1R01CA280081-01		Sharon Ross, Ph.D., M.P.H.
Friday, Bret E.B.	Essentia Institute Of Rural Health United States	Essentia Health Community Cancer Research Program - NCORP	5UG1CA189812-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Furuta, Saori	Case Western Reserve University United States	Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer	5R01CA248304-05
Fuschiotti, Patrizia	University Of Pittsburgh At Pittsburgh United States	Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides	1R21CA280445-01A1		Wendy Wang, Ph.D., M.Sc.
Garcia, Jose M.	Seattle Inst For Biomedical/Clinical Res United States	SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)	1R01CA279220-01A1
Geisler, Stefanie	Washington University United States	Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy	5R37CA267905-03	PAR-19-325 (R01 Clinical Trial Optional)
Germain, Doris A	Icahn School Of Medicine At Mount Sinai United States	Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer.	5R21CA270702-02	PAR-20-292 (R21 Clinical Trial Optional)
Ghamande, Sharad A.	Augusta University United States	Georgia CaRes	5UG1CA189851-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ghobrial, Irene M.	Dana-Farber Cancer Inst United States	Molecular prediction of myeloma in African Americans	5U01CA271492-02	PAR-18-913 (U01 Clinical Trial Not Allowed)
Ghosh, Jayashri	Temple Univ Of The Commonwealth United States	Development of blood-based methylation biomarkers for CRC risk prediction	1R01CA281948-01		Matthew Young, Ph.D.
Ghosh, Moumita	University Of Colorado Denver United States	(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution	5R01CA219893-06		Eva Szabo, M.D.
Giles, Erin	University Of Michigan At Ann Arbor United States	Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?	5R01CA269726-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Godwin, Andrew K.	University Of Kansas Medical Center United States	Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem	3R01CA260132-03S1
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer	2U01CA214254-06
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosomal biomarkers for the early detection of hepatocellular carcinoma	1R01CA271443-01A1		Matthew Young, Ph.D.
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer	5R01CA227602-05
Goggins, Michael G.	Johns Hopkins University United States	Using Markers to Improve Pancreatic Cancer Screening	5R01CA176828-09
Goggins, Michael G.	Johns Hopkins University United States	Using markers to improve pancreatic cancer screening and surveillance: a multi-center study	5U01CA210170-07	PAR-21-334 (U01 Clinical Trial Optional)
Goldman, Radoslav	Georgetown University United States	O-glycoproteins in the progression of liver disease	5R01CA238455-05
Goncalves, Marcus Dasilva	Weill Medical Coll Of Cornell Univ United States	Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival	5R01CA258697-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Goode, Diana J	University Of New England United States	Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy	5R01CA267554-02		Rachel Altshuler, Ph.D.
Grace, Peter M	University Of Tx Md Anderson Can Ctr United States	PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain	5R01CA227064-06
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus	5U2CCA271902-02		Matthew Young, Ph.D.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	High-resolution mutational landscape of the primed colon in early onset colorectal cancer	3U54CA274374-02S1
Gray, Robert J	Dana-Farber Cancer Inst United States	Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)	3U01CA233169-05S1		Rachel Altshuler, Ph.D.
Grimm, Lars J	Duke University United States	Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications	5R01CA271237-02	PAR-19-264 (R01 Clinical Trial Optional)
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer	5U01CA152662-12	RFA-CA-21-033 (U01 Clinical Trial Optional)
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules	5R01CA252964-03
Gross, Howard M	Dayton Clinical Oncology Program United States	Dayton Clinical Oncology Program	5UG1CA189957-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Grueber, Wesley B	Columbia University Health Sciences United States	Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy	5R21CA274588-02		Rachel Altshuler, Ph.D.
Gudas, Lorraine J	Weill Medical Coll Of Cornell Univ United States	CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention	1R01CA270248-01A1		Winfred Malone, Ph.D., M.P.H.
Gunter, Marc James	Imperial College Of Science, Technology And Medicine United States	PROMINENT: Discovering the molecular signatures of cancer PROMotion to INform prevENTion	1OT2CA290880-01
Haab, Brian B.	Van Andel Research Institute United States	Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers	5U01CA226158-05	PAR-17-206 (U01)
Hall, Adam Roger	Wake Forest University Health Sciences United States	Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores	1R33CA246448-01A1	RFA-CA-19-020 (R33 Clinical Trials Not Allowed)	Guillermo Marquez, Ph.D.
Halmos, Balazs	Montefiore Medical Center (Bronx, Ny) United States	MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM	5UG1CA189859-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Hanash, Samir M	University Of Tx Md Anderson Can Ctr United States	Clinical Validation Center for Lung Cancer Early Detection	5U01CA271888-02	RFA-CA-21-033 (U01 Clinical Trial Optional)
Hanks, Brent Allen	Duke University United States	Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities	5R01CA251136-03	PAR-19-325 (R01 Clinical Trial Optional)	Marjorie Perloff, M.D.
Hansen, Laura A	Creighton University United States	Targeting aberrant anti-apoptotic signaling for prevention of skin cancer	5R01CA253573-04		Howard L. Parnes, M.D.
Hartman, Terryl J.	Emory University United States	Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer	5R01CA245063-04
Hawkins, Shannon Michelle	Indiana Univ-Purdue Univ At Indianapolis United States	Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas	5R01HD109707-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Hayes, Richard Bernard	New York University School Of Medicine United States	The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer	5R01CA159036-09
Hecht, Stephen S	University Of Minnesota United States	High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck	5R01CA263084-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Hecht, Stephen S	University Of Minnesota United States	Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens	5R01CA222005-05		Amit Kumar, Ph.D.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	2U01CA200464-06A1
Heinrich, Michael C	Oregon Health & Science University United States	Novel models for functional profiling of germline SDH variants associated with cancer	5R21CA263400-02	PAR-20-292 (R21 Clinical Trial Optional)	Richard Mazurchuk, Ph.D.
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-02		Wendy Wang, Ph.D., M.Sc.
Herrmann, Joerg	Mayo Clinic Rochester United States	TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial	5R01CA233610-06	PA-18-003 (R01 Clinical Trial Optional)	Eileen Dimond, R.N., M.S.
Hilakivi-Clarke, Leena A.	University Of Minnesota United States	Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota	1R01CA276775-01A1		Amit Kumar, Ph.D.
Hill, Joshua Aiden	Fred Hutchinson Cancer Center United States	Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy	1R01CA276040-01A1		Sharon Ross, Ph.D., M.P.H.
Hinds, Pamela S	Children'S Research Institute United States	Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment	5R01CA212190-05
Hirsch, Fred R	Icahn School Of Medicine At Mount Sinai United States	Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses	3U54CA260560-02S2
Hitchins, Megan P	Cedars-Sinai Medical Center United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	5R01CA252042-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Hoffman, Amy Jude	University Of Nebraska Medical Center United States	Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients	5R01CA205025-06
Hofseth, Lorne J	University Of South Carolina At Columbia United States	Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer	3R01CA246809-05S1
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-07	PAR-21-334 (U01 Clinical Trial Optional)
Hoshida, Yujin	Ut Southwestern Medical Center United States	Epigallocatechin gallate for prevention of lethal cirrhosis complications	1R01CA282178-01		Asad Umar, D.V.M., Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	1U01CA288375-01
Hoshida, Yujin	Ut Southwestern Medical Center United States	Reverse-engineering precision liver cancer chemoprevention	3R01CA233794-05S1
Houghton, A Mcgarry	Fred Hutchinson Cancer Center United States	Tumor-specific autoantibodies for SCLC early detection	5R01CA243328-06
Hruska, Carrie B	Mayo Clinic Rochester United States	Density MATTERS Clinical Trial	5R01CA239200-04
Hu, Shuiying	Ohio State University United States	Targeting neuronal transport to ameliorate vincristine neurotoxicity	1R01CA272254-01A1		Rachel Altshuler, Ph.D.
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-02		Nick Hodges, Ph.D.
Huang, Ying	Western University Of Health Sciences United States	Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol	5R01CA269653-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Huberty, Jennifer Lynne	University Of Texas Hlth Science Center United States	Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients	5R01CA262041-03
Huh, Warner King	University Of Alabama At Birmingham United States	Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project)	1R01CA279021-01A1		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Hundley, William Gregory	Wake Forest University Health Sciences United States	Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment	5R33CA226960-04		Eileen Dimond, R.N., M.S.
Hunter, Jessica Ezzell	Kaiser Foundation Research Institute United States	Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer	5U01CA244323-04
Hur, Chin	Columbia University Health Sciences United States	Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype	5R01CA257333-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Hwang, Eun-Sil Shelley	Duke University United States	Breast Pre-Cancer Atlas Center	3U2CCA233254-01S3		Richard Mazurchuk, Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-03	PAR-20-053 (R01 Clinical Trial Not Allowed)
Im, Eun-Ok	University Of Texas At Austin United States	Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors	4R33CA280979-02		Brennan Streck, Ph.D., R.N., M.P.H.
Infante, Rodney E	Ut Southwestern Medical Center United States	Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia	5R01CA266900-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Irvin, William J	Southeast Clinical Oncol Res Consortium United States	NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)	5UG1CA189858-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Iwelunmor, Juliet	Saint Louis University United States	Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)	1U01CA279863-01
Iyer, Prasad G.	Mayo Clinic Rochester United States	Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma	5R01CA241164-05
Jacob, Jennifer B	Wayne State University United States	Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice	1R01CA278818-01A1		Vignesh Gunasekharan, Ph.D.
James, Aimee S	Washington University United States	Building equity in cancer screening through research: The Siteman Catchment CSRN Hub	1UG1CA286946-01		Elyse LeeVan, M.D., M.P.H.
Jaslowski, Anthony J	St. Vincent Hospital United States	Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium	5UG1CA239769-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ji, Hanlee P	Stanford University United States	Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification	1P01CA265772-01A1		Asad Umar, D.V.M., Ph.D.
Jiang, Feng	University Of Maryland Baltimore United States	Plasma biomarkers for lung cancer diagnosis	4UH3CA251139-03
Jiang, Qing	Purdue University United States	Anti-cancer effects of tocotrienols and a carboxychromanol in an innovative colon cancer model	1R03CA283236-01A1
Jim, Heather S.L.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue	5R01CA214647-05		Marge Good, R.N., M.P.H., O.C.N.
Johnson, Constance Margaret	University Of Texas Hlth Sci Ctr Houston United States	The relationship between fMRI and patient-reported outcomes in chemotherapy-induced neuropathy: A diversity supplement	3R01CA245054-04S1		Rachel Altshuler, Ph.D.
Kachnic, Lisa A.	Columbia University Health Sciences United States	Columbia University Minority/Underserved Site NCI Community Oncology Research Program	5UG1CA189960-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kahalley, Lisa Schum	Baylor College Of Medicine United States	Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.	3R01CA249988-03S1
Kahalley, Lisa Schum	Baylor College Of Medicine United States	White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy	5R01CA221197-05
Kalluri, Raghu	University Of Tx Md Anderson Can Ctr United States	Rigorous and reproducible mutational analysis of the urinary exosomal DNA	5R01CA231465-05
Kanwal, Fasiha	Baylor College Of Medicine United States	Risk Stratification for and Early Detection of Liver Cancer	2U01CA230997-06
Kassie, Fekadu	University Of Minnesota United States	Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells	5R01CA231210-05
Katona, Bryson William	University Of Pennsylvania United States	Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants	5R21CA267949-02	PAR-20-292 (R21 Clinical Trial Optional)
Kelleher, Sarah	Duke University United States	Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings	1R21CA273832-01A1
Khan, Seema Ahsan	Northwestern University At Chicago United States	Northwestern Cancer Prevention Consortium	5UG1CA242643-05	RFA-CA-18-029 (UG1 Clinical Trial Required)	Donald Johnsey
Khan, Seema Ahsan	Northwestern University At Chicago United States	Determinants of transdermal drug delivery to the normal and the radiated breast	5R01CA235647-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Khasabov, Sergey G	University Of Minnesota United States	Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling	5R01CA263777-03		Rachel Altshuler, Ph.D.
Kibel, Adam S	Brigham And Women'S Hospital United States	Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer	1U01CA268810-01A1		Richard Mazurchuk, Ph.D.
Kim, Kyungmann	University Of Wisconsin-Madison United States	CP-CTNet Coordinating Center	5U24CA242637-05	RFA-CA-18-030 (U24 Clinical Trials Required)	Donald Johnsey
Kim, Hyung L	Cedars-Sinai Medical Center United States	Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer	1R01CA280060-01A1		Howard L. Parnes, M.D.
King, Suzanne N	University Of Louisville United States	Mechanisms underlying radiation-induced dysphagia	5R21CA263107-02	PAR-20-292 (R21 Clinical Trial Optional)	Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Kingham, T Peter	Sloan-Kettering Inst Can Research United States	Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries	5UH3CA257869-05		Matthew Young, Ph.D.
Kinney, Anita Y.	American Society Of Preventive Oncology, Inc. United States	2024 Annual Conference Grant: American Society of Preventive Oncology	1R13CA290995-01		Wendy Wang, Ph.D., M.Sc.
Kisiel, John	Mayo Clinic Rochester United States	Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation	5R37CA214679-07
Kleckner, Ian Robert	University Of Maryland Baltimore United States	Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation	5R21CA259422-02	PAR-20-292 (R21 Clinical Trial Optional)
Kober, Kord Michael	University Of California, San Francisco United States	An Evaluation of Cloud Computing for Symptom Science Research: Moving Genomics and Machine Learning Analyses of Cancer Chemotherapy-Related Fatigue to the Cloud	3R37CA233774-05S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kolb, Noah Allan	University Of Vermont & St Agric College United States	Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy	5R01CA247517-03
Kong, Mei	University Of California-Irvine United States	Using dietary glutamine supplementation for melanoma prevention and targeted therapy	5R01CA244360-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Kooperberg, Charles L	Fred Hutchinson Cancer Center United States	Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN)	1UG1CA287013-01		Elyse LeeVan, M.D., M.P.H.
Krasnow, Mark A	Stanford University United States	Molecular mechanisms of SCLC initiation and detection in mice and humans	5U01CA231851-05		Eva Szabo, M.D.
Krist, Alexander H	Virginia Commonwealth University United States	Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)	1UG1CA287017-01		Elyse LeeVan, M.D., M.P.H.
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-05
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	1U01CA285013-01
Kuhs, Krystle A.	University Of Kentucky United States	Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal Cancer	5R21CA267152-02
Kulkarni, Swati	Northwestern University At Chicago United States	Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ	5R01CA218436-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kumar, Nagi B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Phase II Clinical trial of GTC in Men on Active Surveillance	5R01CA235032-05		Howard L. Parnes, M.D.
Kupfer, Sonia	University Of Chicago United States	Colonic responses to vitamin D and aspirin in African- and European-Americans	5R01CA220329-05		Gabriela Riscuta, M.D., C.N.S.
Labaer, Joshua	Arizona State University-Tempe Campus United States	Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck	1R33CA281802-01
Labaer, Joshua	Arizona State University-Tempe Campus United States	High-throughput immunoproteomics for cancer biomarker discovery	5U2CCA271903-02		Christos Patriotis, Ph.D., M.Sc.
Lad, Thomas	Hektoen Institute For Medical Research United States	Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal	5UG1CA190000-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ladas, Elena J.	Columbia University Health Sciences United States	Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer	5R01CA201788-07		Gabriela Riscuta, M.D., C.N.S.
Lampe, Paul D	Fred Hutchinson Cancer Center United States	Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer	1R01CA281801-01		Richard Mazurchuk, Ph.D.
Langevin, Anne-Marie R.	University Of Texas Hlth Science Center United States	Texas Pediatric NCORP MU	5UG1CA189855-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Largaespada, David Andrew	University Of Minnesota United States	Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention	5UH3CA244687-05	RFA-CA-19-012
Lee, Jeffrey Kuang Zou	Kaiser Foundation Research Institute United States	Multi-Ethnic Multi-Cancer Early Detection and Screening (MED SCREEN) Study	1UG1CA287011-01		Elyse LeeVan, M.D., M.P.H.
Lee, Hakho	Massachusetts General Hospital United States	Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics	5U01CA233360-05
Lee, Juhun	University Of Pittsburgh At Pittsburgh United States	Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis	5R01CA269540-02
Lee, Hakho	Massachusetts General Hospital United States	Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array	1U01CA284982-01
Lenburg, Marc Elliott	Boston University Medical Campus United States	The Boston University - UCLA Lung Cancer Biomarker Characterization Center	5U2CCA271898-02
Lesser, Glenn J	Wake Forest University Health Sciences United States	Wake Forest NCORP Research Base	5UG1CA189824-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Levine, Jon David	University Of California, San Francisco United States	Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress	5R01CA250017-05		Rachel Altshuler, Ph.D.
Li, Debiao	Cedars-Sinai Medical Center United States	Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images	5R01CA260955-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Li, Christopher I	Fred Hutchinson Cancer Center United States	Fred Hutchinson Breast Cancer Clinical Validation Center	5U01CA152637-13
Li, Hongjin	University Of Illinois At Chicago United States	A Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors	5R21CA277153-02
Li, Chi	University Of Louisville United States	A lung cancer vaccine based on exosomes of induced pluripotent stem cells	1R21CA280453-01		John Clifford, Ph.D.
Li, Yong	Baylor College Of Medicine United States	Cancer Prevention-Interception Against MGUS Progression	1U54CA272691-01A1		Vignesh Gunasekharan, Ph.D.
Li, Bing	University Of Iowa United States	E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function	5R01CA180986-10
Li, Feng	University Of California Los Angeles United States	Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer.	1R21CA283665-01
Liang, Han	University Of Tx Md Anderson Can Ctr United States	The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data	5U24CA264128-02	RFA-CA-21-015 (U24 Clinical Trial Optional)
Lin, Jia-Ren	Harvard Medical School United States	Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images	5R50CA274277-02
Lin, Po-Ju	University Of Rochester United States	Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathy	1R21CA256154-01A1	PAR-20-292 (R21 Clinical Trial Optional)	Marge Good, R.N., M.P.H., O.C.N.
Lin, Daniel W.	Fred Hutchinson Cancer Center United States	Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research	5U01CA224255-06
Lindau, Stacy Tessler	University Of Chicago United States	Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy	1R01CA281301-01A1		Marjorie Perloff, M.D.
Linnes, Jacqueline	Purdue University United States	Point-of-care screening test for early cervical cancer detection	5R01CA246315-04
Lipkin, Steven M	Weill Medical Coll Of Cornell Univ United States	CAP-IT Center for LNP RNA Immunoprevention	5U54CA272688-02	RFA-CA-21-038 (U54 Clinical Trial Not Allowed)
Lipkin, Steven M	Weill Medical Coll Of Cornell Univ United States	(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance	5R01CA231283-05		Asad Umar, D.V.M., Ph.D.
Lipkin, Steven M	Weill Medical Coll Of Cornell Univ United States	Neoantigen Vaccination for Lynch Syndrome Immunoprevention	5U01CA233056-05		Mark Steven Miller, Ph.D.
Liu, Yang	University Of Pittsburgh At Pittsburgh United States	Imaging nanoscale chromatin folding in early carcinogenesis	5R01CA254112-04
Liu, Changchun	University Of Connecticut Sch Of Med/Dnt United States	Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care	5U01CA269147-02
Livneh, Zvi	Weizmann Institute Of Science United States	Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort	1U01CA279001-01		Claire Zhu, Ph.D.
Lok, Anna S.F.	University Of Michigan At Ann Arbor United States	NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION	5U01CA230669-05
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer	5R01CA254036-04
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms	5R01CA247220-04
Lopez-Bigas, Nuria	Fundacio Institut De Recerca Biomedica United States	PROMINENT - IRB	3OT2CA278668-01S1
Lu, Junxuan	Pennsylvania State Univ Hershey Med Ctr United States	Early clinial trials for Angelica herbal supplements for prostate cancer interception	5R01CA260901-02	PAR-21-035 (R01 Clinical Trial Required)
Lubman, David M	University Of Michigan At Ann Arbor United States	Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach	5R01CA160254-12
Lukenbill, Joshua Cole	Iowa Oncology Research Association United States	Iowa-Wide Oncology Research Coalition (I-WORC)	5UG1CA189816-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Lundberg, Emma	Stanford University United States	PROMINENT - Stanford	3OT2CA278713-01S1
Lyden, David Charles	Weill Medical Coll Of Cornell Univ United States	Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection	2R01CA218513-06A1	PAR-16-276 (R01)
Maclean, Paul S.	University Of Colorado Denver United States	Novel dietary interventions for reducing obesity-associated breast cancer	5R01CA258766-03
Madeleine, Margaret M	Fred Hutchinson Cancer Center United States	Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center	5U54CA242977-06		Silvina Frech, Ph.D., M.S.
Maitra, Anirban	University Of Tx Md Anderson Can Ctr United States	Clinical Validation Center for Early Detection of Pancreatic Cancer	5U01CA200468-07
Maitra, Anirban	University Of Tx Md Anderson Can Ctr United States	Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies	5R01CA218230-05	PAR-16-276 (R01)	Matthew Young, Ph.D.
Majumder, Shounak	Mayo Clinic Rochester United States	Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer	5U01CA210138-07	PAR-21-334 (U01 Clinical Trial Optional)
Malafa, Mokenge P	H. Lee Moffitt Cancer Ctr & Res Inst United States	Novel Therapy to Inhibit IPMN Progression	5R01CA263575-02
Maldonado, Fabien	Vanderbilt University Medical Center United States	Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures	5R01CA253923-04
Mallery, Susan R	Ohio State University United States	Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention	5R01CA258757-02	PAR-21-035 (R01 Clinical Trial Required)	Malgorzata (Margaret) Wojtowicz, M.D.
Mallery, Susan R	Ohio State University United States	Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions	5R01CA227273-05
Mallick, Parag Kumar	Stanford University United States	Pathomic Predictors of Prostate Cancer Progression	5R01CA249899-05	PAR-19-264 (R01 Clinical Trial Optional)
Mantis, Nicholas J.	Wadsworth Center United States	High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology	3U01CA260508-02S1
Mao, Jun J	Sloan-Kettering Inst Can Research United States	Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE)	5R01CA240417-04
Mao, Jun J	Sloan-Kettering Inst Can Research United States	Dopamine Metabolism and Nonpharmacologic Insomnia Interventions Among Cancer Survivors	5R21CA274059-02
Marchand, Loic Le	University Of Hawaii At Manoa United States	Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial	5R01CA258179-03	RFA-CA-20-004 (R01 Clinical Trial Optional)
Marchetti, Dario	University Of New Mexico Health Scis Ctr United States	Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF	5R01CA216991-07
Markowitz, Sanford D.	Case Western Reserve University United States	Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation	5U01CA271867-02	RFA-CA-21-033 (U01 Clinical Trial Optional)
Marshall, David T.	Medical University Of South Carolina United States	Medical University of South Carolina NCORP Minority/Underserved Community Site	5UG1CA189848-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Masters, Gregory A	Christiana Care Health Services, Inc. United States	Delaware Christiana Care NCORP	5UG1CA189819-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Matin, Khalid	Virginia Commonwealth University United States	VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program	5UG1CA189869-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mcdonald, Andrew M	University Of Alabama At Birmingham United States	A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer	5R21CA259808-02		Howard L. Parnes, M.D.
Mcguire, Andrew	Fred Hutchinson Cancer Center United States	Rational Vaccine Design to prevent HIV-Associated Lymphoma	1R01CA285227-01A1		Winfred Malone, Ph.D., M.P.H.
Mckeon, Frank D.	University Of Houston United States	Clonal Reconstruction and Targeting of the Correa Sequence	5R01CA241600-05
Mclouth, Laurie	University Of Kentucky United States	Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment	1R01CA283929-01		Brennan Streck, Ph.D., R.N., M.P.H.
Md, Nicholas Dibella	Western States Cancer Research Ncorp United States	Western States Cancer Research NCORP	5UG1CA189805-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Meghani, Salimah H.	University Of Pennsylvania United States	Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study	3R01CA270483-02S1	PA-18-917 (R01 - Clinical Trial Optional)	Sharon Ross, Ph.D., M.P.H.
Mehrara, Babak J	Sloan-Kettering Inst Can Research United States	Mechanisms of racial disparity in breast cancer-related lymphedema	5R01CA278599-02
Mehta, Anand S	Medical University Of South Carolina United States	Glycopathology of HCC: identification of the source cells of serum fucosylation	5U01CA226052-05	PAR-17-206 (U01)
Mehta, Anand S	Medical University Of South Carolina United States	Translation of a biomarker panel for the early detection of hepatocellular carcinoma	5R01CA237659-05
Melemedjian, Ohannes Kevork	University Of Maryland Baltimore United States	Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy	1R01CA249939-01		Rachel Altshuler, Ph.D.
Meltzer, Stephen J	Johns Hopkins University United States	Facile screening for esophageal cancer in LMICs	5UH3CA211457-05		Matthew Young, Ph.D.
Metzger, Gregory John	University Of Minnesota United States	Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI	5R01CA241159-03
Milanovich, Samuel J	Sanford Research/Usd United States	Sanford Community Cancer Program of the North Central Plains (NCORP)	5UG1CA189825-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Milbury, Kathrin	University Of Tx Md Anderson Can Ctr United States	Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers	5R37CA231522-06		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mishra, Lopa	Feinstein Institute For Medical Research United States	Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer	7U01CA230690-06
Mohile, Supriya G	University Of Rochester United States	Understanding Treatment Tolerability in Older Patients with Cancer	3U01CA233167-05S1		Rachel Altshuler, Ph.D.
Moore, Timothy David	Columbus Community Clinical Oncology Prg United States	Columbus NCORP RFA-CA-18-016	5UG1CA189954-10
Morilak, David A	University Of Texas Hlth Science Center United States	Therapy-induced cognitive impairment in a rat model of prostate cancer	1R01CA285183-01		Catherine Schweppe, Ph.D.
Morilak, David A	University Of Texas Hlth Science Center United States	Cognitive impairment associated with androgen deprivation therapy for prostate cancer	5R01CA224672-05
Moscicki, Anna-Barbara	University Of California Los Angeles United States	Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies	1R01CA281293-01		Silvina Frech, Ph.D., M.S.
Moyer, Matthew T.	Pennsylvania State Univ Hershey Med Ctr United States	CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial	5R01CA222648-05		Asad Umar, D.V.M., Ph.D.
Mugo, Nelly Rwamba	Kenya Medical Research Institute (Kemri) United States	KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH	1UG1CA285132-01		Silvina Frech, Ph.D., M.S.
Muller, Carolyn Y	University Of New Mexico Health Scis Ctr United States	NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites	5UG1CA189856-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mungo, Chemtai Chemtai	Univ Of North Carolina Chapel Hill United States	Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs	1R34CA284983-01		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Murenzi, Gad	Research For Development United States	Rwanda CASCADE Clinical Trials Site for cervical cancer prevention	1UG1CA284908-01		Silvina Frech, Ph.D., M.S.
Murphy, Elizabeth Angela	University Of South Carolina At Columbia United States	A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal Cancer - admin supplement	3U01CA272977-02S1
Mustian, Karen M.	University Of Rochester United States	Sexual Orientation and Gender Identity Data Collection in Community Oncology Practice	3UG1CA189961-10S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mwesigwa, Betty	Makerere University Walter Reed Project United States	Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA)	5UG1CA275412-02		Silvina Frech, Ph.D., M.S.
Naicker, Nivashnee	Centre/Aids Programme/Res/South Africa United States	CAPRISA CASCADE Clinical Trials Network Clinical Research Site	1UG1CA284671-01		Silvina Frech, Ph.D., M.S.
Nappi, Lucia	Provincial Health Services Authority United States	Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration.	5R37CA264798-02	PAR-19-264 (R01 Clinical Trial Optional)
Nath, Kavindra	University Of Pennsylvania United States	Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition	5R01CA228457-05
Nathan, Cherie-Ann O	Louisiana State Univ Hsc Shreveport United States	Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.	5R01CA217180-05		Howard L. Parnes, M.D.
Nautiyal, Shivani	Prime Genomics, Inc. United States	Device for Preservation of Cell Free RNA in Saliva	5R21CA258013-02		Guillermo Marquez, Ph.D.
Nechiporuk, Alex	Oregon Health & Science University United States	High-throughput identification of molecular targets responsible for drug-induced peripheral neuropathies.	1R21CA260025-01A1		Rachel Altshuler, Ph.D.
Nelson, Randy J.	West Virginia University United States	Mechanism Underlying Sleep Disruption by Mammary Tumors	5R21CA276027-02
Neslund-Dudas, Christine Marie	Henry Ford Health + Michigan State University Health Sciences United States	HFH-MSU CSRN ACCrual Enrollment and Screening Site	1UG1CA287007-01		Elyse LeeVan, M.D., M.P.H.
Nicolson, Fay	Dana-Farber Cancer Inst United States	SESORRS endoscopy for the staging and evaluation of colorectal cancer	4R00CA266921-03		Gary Della'Zanna, D.O., M.Sc.
Noble, Mark D	University Of Rochester United States	Prevention and treatment of paclitaxel-induced peripheral neuropathy	5R21CA277447-02		Rachel Altshuler, Ph.D.
Nolan, Michael Warren	North Carolina State University Raleigh United States	Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer	5R37CA248797-04
Nyamathi, Adeline M	University Of California-Irvine United States	Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India	1R01CA285063-01		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Nyante, Sarah Jane	Univ Of North Carolina Chapel Hill United States	Understanding the biological basis for the association between parenchymal texture features and breast cancer risk	5R01CA237129-05
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-02	PAR-21-335 (U24 Clinical Trial Not Allowed)
Ochoa, Augusto C.	Lsu Health Sciences Center United States	Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)	3UG1CA189854-10S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ogilvie, Gina	University Of British Columbia United States	Addressing emerging health system priorities in cervical cancer prevention: determining optimal strategies for human papillomavirus test-based screening and triage	5R01CA221918-05		Claire Zhu, Ph.D.
Olopade, Olufunmilayo F.	University Of Chicago United States	Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)	1R01CA276652-01A1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ondrey, Frank G.	University Of Minnesota United States	Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia	5R01CA254270-02	PAR-21-035 (R01 Clinical Trial Required)
Onitilo, Adedayo A	Marshfield Clinic Research Foundation United States	Wisconsin NCI Community Oncology Research Program (WiNCORP)	5UG1CA189956-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Osarogiagbon, Raymond U	Baptist Memorial Hospital - Tipton United States	Baptist Memorial Health Care/Mid South NCORP Minority Underserved Consortium	5UG1CA189873-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	1R21CA274021-01A1		Guillermo Marquez, Ph.D.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer	5R21CA245651-03		Matthew Young, Ph.D.
Palefsky, Joel Michael	University Of California, San Francisco United States	California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations	3U54CA242646-05S1		Silvina Frech, Ph.D., M.S.
Palesh, Oxana G	Virginia Commonwealth University United States	Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia	5R01CA239714-06		Marge Good, R.N., M.P.H., O.C.N.
Panda, Satchidananda	Salk Institute For Biological Studies United States	Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function	3R01CA258221-03S1	RFA-CA-20-004 (R01 Clinical Trial Optional)
Pandharipande, Pari Vijay	Ohio State University United States	Precision Management of Cystic Precursors to Pancreatic Cancer	5R01CA237133-06		Matthew Young, Ph.D.
Panigrahy, Dipak	Beth Israel Deaconess Medical Center United States	Control of cancer cachexia via stimulation of resolution of inflammation	1R01CA276107-01A1
Panikkar, Rajiv	Geisinger Clinic United States	Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)	5UG1CA189847-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Park, Youngkyu	Cold Spring Harbor Laboratory United States	Preclinical Models for Cancer Therapeutic Development	5R50CA211506-08
Park, Kwon-Sik	University Of Virginia United States	Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC	5U01CA224293-05		Eva Szabo, M.D.
Paskett, Electra D.	Alliance Nctn Foundation United States	Alliance NCORP Research Base - BIQSFP GY10 Supplements	3UG1CA189823-10S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Patel, Abhijit	Yale University United States	Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood	5U01CA233364-05
Paulovich, Amanda G	Fred Hutchinson Cancer Center United States	Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment	1U2CCA271873-01A1		Sidney Fu, M.D.
Paulson, Thomas G	Fred Hutchinson Cancer Center United States	The microbiome ecosystem of Barrett's esophagus and progression to cancer	5R21CA259687-02	PAR-20-292 (R21 Clinical Trial Optional)
Paus, Ralf	University Of Miami School Of Medicine United States	Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia	1R21CA277418-01A1		Rachel Altshuler, Ph.D.
Penedo, Frank J	University Of Miami Coral Gables United States	eHealth Supported Mindfulness-based Music Therapy Intervention (eMBMT) in Hemopoietic Stem Cell Transplant Patients	5R61CA263335-02
Peppone, Luke Joseph	University Of Rochester United States	High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients	5R01CA258349-03	PAR-21-035 (R01 Clinical Trial Required)
Perelman, Lev T	Beth Israel Deaconess Medical Center United States	Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression	5R01CA228029-06
Perlis, Michael Lloyd	University Of Pennsylvania United States	The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients	1R21CA270987-01	PAR-20-292 (R21 Clinical Trial Optional)	Marge Good, R.N., M.P.H., O.C.N.
Permuth, Jennifer B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	5R37CA229810-05
Peters, Jeffrey M	Pennsylvania State University, The United States	Unique targeting of PPARβ/δ regulation for cancer prevention and therapy	5R01CA239256-05
Phd, Ralph Weissleder, Md,	Massachusetts General Hospital United States	Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)	5R01CA237332-04	PAR-16-276 (R01)
Phillips, Nicholas S	St. Jude Children'S Research Hospital United States	Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma	1R61CA280978-01
Phillips, Nicholas S	St. Jude Children'S Research Hospital United States	Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors	1R21CA280230-01A1		Eileen Dimond, R.N., M.S.
Pinder, Leeya F	University Of Cincinnati United States	RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial)	1R37CA284033-01		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Pitteri, Sharon	Stanford University United States	Glycosylation and Immune Evasion in Urologic Tumors	5U01CA226051-05
Plas, Ellen Van Der	Arkansas Children'S Hospital Res Inst United States	Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia	5R37CA266135-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Pollock, Brad H	Public Health Institute United States	Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base Grant	3UG1CA189955-10S2		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Porter, Laura S	Duke University United States	Couple Communication Skills Training for Advanced Cancer	5R01CA229425-05
Pozdeyev, Nikita	University Of Colorado Denver United States	Genetic architecture of thyroid cancer and its clinical utility	1R21CA282380-01A1
Punnen, Sanoj	University Of Miami School Of Medicine United States	The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection	1R01CA272766-01A1		Matthew Young, Ph.D.
Pyter, Leah M	Ohio State University United States	Chemotherapy-induced circadian master clock disruptions and fatigue	3R01CA270372-02S1	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Radisky, Derek C	Mayo Clinic Jacksonville United States	Involution-based biomarkers of breast cancer risk	3R01CA237602-04S1
Ragin, Camille C	Research Inst Of Fox Chase Can Ctr United States	Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry	1R13CA284826-01
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-10
Ramanujam, Nirmala	Duke University United States	Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening	5U01CA269192-02
Rapaport, Mark Hyman	University Of Utah United States	Massage for Prostate Cancer-Related Fatigue	1R21CA263453-01	PAR-20-292 (R21 Clinical Trial Optional)	Goli Samimi, Ph.D., M.P.H.
Reese, Jennifer Barsky	Research Inst Of Fox Chase Can Ctr United States	Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention	5R01CA222124-05		Ellen Richmond, M.S., G.N.P.-B.C.
Remick, Scot C	Mainehealth United States	MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan	5UG1CA239771-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Reuland, Daniel S.	Univ Of North Carolina Chapel Hill United States	Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB)	1UG1CA286949-01		Elyse LeeVan, M.D., M.P.H.
Richards-Kortum, Rebecca R.	Rice University United States	Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer	5R01CA251911-04
Rini, Christine	Northwestern University At Chicago United States	Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial	5R01CA271220-02	PAR-21-035 (R01 Clinical Trial Required)
Robbins, Hilary A.	International Agency For Res On Cancer United States	The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening	5R01CA262164-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Robertson, Gavin P.	Pennsylvania State Univ Hershey Med Ctr United States	Targeting Aldehyde Dehydrogenase for Cancer Prevention	5R01CA241148-05
Robien, Kimberly Z	George Washington University United States	Body composition and chemotherapy toxicity among women being treated for breast cancer	5R21CA259790-02		Sharon Ross, Ph.D., M.P.H.
Rodriguez, Gustavo	Northshore University Healthsystem United States	Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer	3R01CA214606-05S1		Marjorie Perloff, M.D.
Rogers, Laura Q	University Of Alabama At Birmingham United States	Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors	5R01CA235598-05		Gabriela Riscuta, M.D., C.N.S.
Rohan, Thomas E	Albert Einstein College Of Medicine United States	Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ	5R01CA218429-06		Christos Patriotis, Ph.D., M.Sc.
Rosenberg, Daniel William	University Of Connecticut Sch Of Med/Dnt United States	Microbiota, Metabolites, and Colon Neoplasia	5R01CA252045-03	PA-18-902 (R01 Clinical Trial Optional)
Rosenberg, Abby R	Dana-Farber Cancer Inst United States	The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer	7R01CA222486-06		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rosenbluth, Jennifer M	University Of California, San Francisco United States	In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer	5R01CA281361-02		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-02		Rachel Altshuler, Ph.D.
Rosser, Charles J	Cedars-Sinai Medical Center United States	A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology	5R01CA277810-02
Rotemberg, Veronica Miriam	Sloan-Kettering Inst Can Research United States	M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection	5U24CA264369-02		Guillermo Marquez, Ph.D.
Rowland, Kendrith Martin	Carle Foundation United States	Carle Cancer Center NCI Community Oncology Research Program (NCORP)	5UG1CA189861-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rozengurt, Juan Enrique	University Of California Los Angeles United States	Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression	5R21CA258125-02
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07
Saenger, Yvonne Margaret	Albert Einstein College Of Medicine United States	Applying pathomics to establish a biosignature for aggressive skin melanoma	5R01CA260375-03
Salami, Simpa Samuel	University Of Michigan At Ann Arbor United States	Defining the Biological Arc of Grade Group 1 Prostate Cancer	1R37CA283857-01		Guillermo Marquez, Ph.D.
Salman, Emad	Florida Assn Of Pediatric Tumor Prog United States	The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program.	5UG1CA189973-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Salvemini, Daniela	Saint Louis University United States	A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity	5R01CA230512-05		Rachel Altshuler, Ph.D.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-02		Rachel Altshuler, Ph.D.
Sanda, Martin G	Emory University United States	Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern	2U01CA113913-16A1
Sands, Stephen Alan	Sloan-Kettering Inst Can Research United States	Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)	1R01CA283045-01		Catherine Schweppe, Ph.D.
Sant, Shilpa	University Of Illinois At Chicago United States	Three-dimensional organoid models to study breast cancer progression	4R37CA232209-06
Santos-Reyes, Luis Javier	Comprehensive Cancer Center/ Univ/Pr United States	Puerto Rico Minority Underserved NCI Community Oncology Research Program (Puerto Rico MUNCORP)	5UG1CA189862-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Saphner, Thomas J	Aurora Health Care, Inc. United States	Aurora NCORP Community Site	5UG1CA190140-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Sariol, Carlos A	University Of Puerto Rico Med Sciences United States	SARS-CoV-2 correlates of protection in a Latino-origin population	3U01CA260541-02S1		Guillermo Marquez, Ph.D.
Schallenkamp, John M.	Montana Cancer Consortium United States	Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming	5UG1CA189872-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schedin, Pepper J	Oregon Health & Science University United States	NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention	5R01CA169175-11
Schloss, Patrick David	University Of Michigan At Ann Arbor United States	muMS2: an open source R package for analyzing and integrating multi-omics datasets to improve early detection and understanding of colorectal cancer	5U01CA264071-02	RFA-CA-21-014 (U01 Clinical Trial Optional)
Schmidt, Christian Maximillian	Indiana Univ-Purdue Univ At Indianapolis United States	Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer	5U01CA239522-04	PAR-18-913 (U01 Clinical Trial Not Allowed)
Schmit, Stephanie L	Cleveland Clinic Lerner Com-Cwru United States	Variation in tumor-associated immune profiles and colorectal cancer outcomes	5R01CA248931-03
Schoen, Robert E.	University Of Pittsburgh At Pittsburgh United States	Blood-Based Testing for Advanced Adenoma	5U01CA271884-02	RFA-CA-21-033 (U01 Clinical Trial Optional)
Schroeck, Florian R	Veterans Education/Res/Assn/North/Ne United States	Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance	1R37CA275916-01		Claire Zhu, Ph.D.
Sears, Rosalie C	Oregon Health & Science University United States	Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs	1U01CA278923-01		Matthew Young, Ph.D.
Sedrak, Mina S	University Of California Los Angeles United States	Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline	1R01CA280088-01		Goli Samimi, Ph.D., M.P.H.
Sedrak, Mina S	University Of California Los Angeles United States	Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors	5R21CA277660-03
Segal, Leopoldo Nicolas	New York University School Of Medicine United States	Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer	1U2CCA271890-01A1		Guillermo Marquez, Ph.D.
Sehgal, Ashwini	Case Western Reserve University United States	Pain and Immobility After Breast Cancer Surgery: A Community-Based Randomized Controlled Trial of Myofascial Massage Treatment	5R01CA229287-04		Goli Samimi, Ph.D., M.P.H.
Semmes, Oliver John	Eastern Virginia Medical School United States	Virginia-UCLA-Toronto Biomarker Characterization Center	5U2CCA271894-02		Indu Kohaar, Ph.D.
Sempere, Lorenzo	Michigan State University United States	Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer	5R01CA258314-03		Edward Sauter, M.D., Ph.D.
Sen, Subrata	University Of Tx Md Anderson Can Ctr United States	Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer	5U01CA214263-05
Shah, Sohrab	Sloan-Kettering Inst Can Research United States	Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer	1R01CA281928-01		Christos Patriotis, Ph.D., M.Sc.
Shalon, Tidhar Dari	Envivo Bio Inc United States	Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring	4R33CA260665-02		Sharon Ross, Ph.D., M.P.H.
Shelby, Rebecca A	Duke University United States	Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis	5R01CA249959-05
Shen, Chan	Pennsylvania State Univ Hershey Med Ctr United States	The effects of hydrocodone rescheduling on pain management of older lung cancer patients	1R21CA277849-01		Rachel Altshuler, Ph.D.
Shen, Qiang	Lsu Health Sciences Center United States	Chemoprevention of Breast Cancer by Targeting Glucose Metabolism with HJC0152	5R01CA226001-06
Sherman, Mark E	Mayo Clinic Jacksonville United States	Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)	5R01CA262393-03		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Shu, Xiao-Ou	Vanderbilt University Medical Center United States	Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer	5R01CA227133-05		Matthew Young, Ph.D.
Shuck, Sarah C.	Beckman Research Institute/City Of Hope United States	Identification of metabolic adducts associated with prostate cancer progression in African American men	1R21CA282612-01		Guillermo Marquez, Ph.D.
Shureiqi, Imad	University Of Michigan At Ann Arbor United States	ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism	5R01CA266223-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Siddique, Shahzad	Commonspirit Health Research Institute United States	CIRI Oncology Research Alliance	5UG1CA189809-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Sidransky, David	Johns Hopkins University United States	Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma	5R01CA265975-02
Sieren, Jessica C	University Of Iowa United States	Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers	5R01CA267820-02		Nick Hodges, Ph.D.
Sigel, Keith Magnus	Icahn School Of Medicine At Mount Sinai United States	The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors	5R01CA256660-03
Simeone, Diane M	New York University School Of Medicine United States	Biomarker Validation in Pancreatic Cystic Neoplasms	1U01CA282272-01
Siminski, Suzanne M.	Frontier Sci & Technology Rsch Fdn, Inc United States	CASCADE Coordinating Center	5U24CA275417-02		Silvina Frech, Ph.D., M.S.
Simone, Donald	University Of Minnesota United States	Neural Mechanisms of Cancer Pain	5R01CA241627-05		Rachel Altshuler, Ph.D.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis	5R01CA222900-06
Singal, Amit	Ut Southwestern Medical Center United States	Clinical Validation Center for Hepatocellular Carcinoma	5U01CA271887-02
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules	1U01CA283935-01		Matthew Young, Ph.D.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States	5U01CA230694-05
Singh, Shivendra	University Of Pittsburgh At Pittsburgh United States	Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer	5R01CA225716-05		Howard L. Parnes, M.D.
Singh, Shivendra	University Of Pittsburgh At Pittsburgh United States	The Role of FoxQ1 in Breast Cancer Chemoprevention by Allium Constituents - R01CA219180	5R01CA219180-05
Sirica, Alphonse E	Federation Of Amer Soc For Exper Biology United States	The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine	1R13CA284494-01		Wendy Wang, Ph.D., M.Sc.
Skates, Steven J	Massachusetts General Hospital United States	Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls	5U01CA260758-03	PAR-18-913 (U01 Clinical Trial Not Allowed)
Skates, Steven J	Massachusetts General Hospital United States	Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer	5U2CCA271871-02		Christos Patriotis, Ph.D., M.Sc.
Skubitz, Amy Patrice	University Of Minnesota United States	A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection	5R01CA262153-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Slager, Susan L	Mayo Clinic Rochester United States	The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)	5R01CA258465-02
Smalley, Keiran	H. Lee Moffitt Cancer Ctr & Res Inst United States	Defining and targeting the epigenetic programs involved in melanoma development	5R21CA267141-02	PAR-20-292 (R21 Clinical Trial Optional)	Winfred Malone, Ph.D., M.P.H.
Smith, Jennifer Susan	Univ Of North Carolina Chapel Hill United States	UNC CASCADE Network Research Base	5UG1CA275403-02		Silvina Frech, Ph.D., M.S.
Smith, Ellen Mary Lavoie	University Of Alabama At Birmingham United States	Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study	5R01CA235726-07
Snyder, Michael P.	Stanford University United States	Precancer Atlas of Familial Adenomatous Polyposis	3U2CCA233311-01S1		Richard Mazurchuk, Ph.D.
Sohl, Stephanie Jean	Wake Forest University Health Sciences United States	REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE)	5R01CA266995-02	PAR-21-035 (R01 Clinical Trial Required)	Goli Samimi, Ph.D., M.P.H.
Somers, Tamara J	Duke University United States	A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial	5R01CA237892-05
Song, Ming	University Of Louisville United States	Dietary fructose and NASH/HCC progression	1R21CA290420-01
Soragni, Alice	University Of California Los Angeles United States	Targeting p53 conformational defects to arrest carcinogenesis	5R01CA240718-05
Sorger, Peter Karl	Harvard Medical School United States	Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center)	3U2CCA233262-01S2		Sudhir Srivastava, Ph.D., M.P.H.
Sorror, Mohamed	Fred Hutchinson Cancer Center United States	Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality	5R01CA227092-06
Sowers, Lawrence C	University Of Texas Med Br Galveston United States	Cytosine Deamination Adducts and Cancer Etiology	5R01CA228085-05
Spiegel, Brennan	Cedars-Sinai Medical Center United States	Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	5R01CA252211-03		Rachel Altshuler, Ph.D.
Spira, Avrum E	Boston University Medical Campus United States	The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy	1U2CCA233238-01		Richard Mazurchuk, Ph.D.
Stabile, Laura P.	University Of Pittsburgh At Pittsburgh United States	Super-Resolution Imaging of Higher-Order Heterochromatin Structure for Early Detection of Lung Carcinogenesis	5R21CA259787-02	PAR-20-292 (R21 Clinical Trial Optional)
Stachler, Matthew D	University Of California, San Francisco United States	Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus	5R37CA269649-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Staff, Nathan P	Mayo Clinic Rochester United States	Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity	5R01CA275870-02		Rachel Altshuler, Ph.D.
Stolley, Melinda R	Medical College Of Wisconsin United States	Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors	3R01CA229546-05S1		Sharon Ross, Ph.D., M.P.H.
Stolley, Melinda R	Medical College Of Wisconsin United States	Every Day Counts: A lifestyle program for women metastatic breast cancer	5R01CA258759-03	PAR-18-893 (R01 Clinical Trial Optional)
Storz, Peter	Mayo Clinic Jacksonville United States	Deiminated molecules as markers for developing pancreatic cancer - A1	1R21CA279916-01A1
Suga, Jennifer Marie	Kaiser Foundation Research Institute United States	Kaiser Permanente NCI National Community Oncology Research Program, NCORP	5UG1CA189821-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Sukumar, Saraswati	Johns Hopkins University United States	Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership	1R01CA278816-01		Matthew Young, Ph.D.
Sun, Ju	University Of Minnesota United States	SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data	1R01CA287413-01		Amanda Skarlupka, Ph.D.
Suter, Melissa J	Massachusetts General Hospital United States	Early Detection and Diagnosis of Lung Cancer with Endomicroscopy	5R01CA255326-02		Guillermo Marquez, Ph.D.
Svatek, Robert Scott	University Of Texas Hlth Science Center United States	eRapa for bladder cancer prevention	5R01CA252057-04	PAR-19-183 (R01 Clinical Trial Optional)	Howard L. Parnes, M.D.
Tamrazi, Benita	Children'S Hospital Of Los Angeles United States	Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors	5R21CA262978-02		Rachel Altshuler, Ph.D.
Tanasova, Marina	Michigan Technological University United States	Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications	2R15CA242401-02A1
Tangen, Catherine M.	Fred Hutchinson Cancer Center United States	PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research	5U01CA182883-11		Howard L. Parnes, M.D.
Taouli, Bachir	Icahn School Of Medicine At Mount Sinai United States	Abbreviated MRI for HCC screening in cirrhotic patients	5R01CA249765-04
Taratula, Oleh	Oregon State University United States	Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia	5R37CA234006-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tayob, Nabihah	Dana-Farber Cancer Inst United States	Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma	5R01CA230503-06
Temprosa, Marinella	George Washington University United States	22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center	2U01DK048489-28		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Terry, Kathryn L	Brigham And Women'S Hospital United States	Changing Contraceptive Patterns and Ovarian Cancer Risk	5R01CA258679-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Thakur, Mathew Laxman	Thomas Jefferson University United States	Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer	5R01CA249921-04
Thangaraju, Muthusamy	Augusta University United States	Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis	1R01CA275840-01A1		Winfred Malone, Ph.D., M.P.H.
Thomas, Christoforos	Methodist Hospital Research Institute United States	Exploring the role of ER Beta in disease penetrance in individuals with Li-Fraumeni syndrome	5R21CA267386-03	PAR-20-292 (R21 Clinical Trial Optional)	Winfred Malone, Ph.D., M.P.H.
Thompson, Patricia Ann	State University New York Stony Brook United States	Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk	5R01CA235720-05
Tighiouart, Mourad	Cedars-Sinai Medical Center United States	Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials	3U01CA232859-05S1		Rachel Altshuler, Ph.D.
Tollefsbol, Trygve O	University Of Alabama At Birmingham United States	Combinatorial epigenetic-based prevention of breast cancer	5R01CA178441-09
Toriola, Adetunji T	Washington University United States	Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention	5R37CA235602-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Torres, Keila Enitt	University Of Tx Md Anderson Can Ctr United States	Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs	1R01CA285980-01		Richard Mazurchuk, Ph.D.
Turesky, Robert J.	University Of Minnesota United States	DNA adductomics of the urinary system	5R01CA220367-06		Wendy Wang, Ph.D., M.Sc.
Tussing-Humphreys, Lisa	University Of Illinois At Chicago United States	Mediating Role of Gut Microbiota in the Regulation of Colorectal Cancer Risk in the Context of Time-restricted Eating and Calorie Restriction	3R01CA257807-03S1	RFA-CA-20-004 (R01 Clinical Trial Optional)
Ulrich, Cornelia M	University Of Utah United States	Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link	5R01CA254108-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Umbricht, Christopher B	Johns Hopkins University United States	Discovery and validation of early molecular breast cancer risk markers in benign breast disease	5R01CA222779-06
Valdez, Erin G	Stanford University United States	Circadian regulation of cancer therapy-associated neuroinflammation	5R21CA267135-02	PAR-20-292 (R21 Clinical Trial Optional)
Valdimarsdottir, Heiddis	Icahn School Of Medicine At Mount Sinai United States	Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation	5R01CA260961-02	PAR-21-035 (R01 Clinical Trial Required)
Varmus, Harold E.	Weill Medical Coll Of Cornell Univ United States	Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells	5U01CA224326-05		Eva Szabo, M.D.
Velculescu, Victor E.	Johns Hopkins University United States	DNA evaluation of fragments for early interception (DELFI) of Lung cancer	1U01CA271896-01A1
Vigneron, Daniel B	University Of California, San Francisco United States	Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients	5U01CA232320-05	PAR-16-089 (U01)
Vilar-Sanchez, Eduardo	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception for Lynch Syndrome	5R01CA257375-03
Vilar-Sanchez, Eduardo	University Of Tx Md Anderson Can Ctr United States	iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium	5UG1CA242609-05		Donald Johnsey
Vilar-Sanchez, Eduardo	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome	5R01CA260761-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Villanueva, Augusto	Icahn School Of Medicine At Mount Sinai United States	Liquid biopsy and radiomics for liver cancer surveillance	1U01CA283931-01		Matthew Young, Ph.D.
Vinciguerra, Vincent P	Feinstein Institute For Medical Research United States	Northwell Health NCORP	5UG1CA189850-10		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Visovsky, Constance G.	University Of South Florida United States	Home-Based Physical Activity Intervention for Taxane-Induced CIPN	5R01CA229681-05		Goli Samimi, Ph.D., M.P.H.
Wagner, Lynne I.	Ecog-Acrin Medical Research Foundation United States	ECOG-ACRIN NCORP Research Base - TMIST	3UG1CA189828-10S1
Wallace, Douglas C	Children'S Hosp Of Philadelphia United States	Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA	5R01CA259635-02	PAR-19-198 (R01 Clinical Trial Not Allowed)
Wang, Thomas D	University Of Michigan At Ann Arbor United States	Early detection of colorectal cancer in the traditional and serrated pathways	5R01CA249851-04	PAR-19-264 (R01 Clinical Trial Optional)
Wang, Tza-Huei Jeff	Johns Hopkins University United States	A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies	5R33CA272321-02
Wang, Jing	New York University School Of Medicine United States	Optimizing the use of ketamine to reduce chronic postsurgical pain	5UH3CA261067-04
Wang, Hsiao-Lan	University Of Alabama At Birmingham United States	A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment	5R01CA244947-05
Wang, Tza-Huei Jeff	Johns Hopkins University United States	Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women	5R01CA260628-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Washington, Karla	Washington University United States	Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care	3R01CA258311-03S1
Watt, Gordon Patrick	Sloan-Kettering Inst Can Research United States	Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk	1R37CA284134-01A1
Weaver, Alissa M	Vanderbilt University United States	Phenotype Interactions in SCLC Development and Detection	5U01CA224276-05		Eva Szabo, M.D.
Webster, Nicholas J	University Of California, San Diego United States	Time-restricted feeding and breast cancer	5R01CA196853-07	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Webster, Nicholas J	Veterans Medical Research Fdn/San Diego United States	The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer	1R21CA288777-01
Wei, Lei	Roswell Park Cancer Institute Corp United States	Advancing skin cancer prevention by tackling UV-induced clonogenic mutations	5R01CA255242-04
Welsh, Joellen	State University Of New York At Albany United States	Vitamin K: Body Pools and Function in Breast Cancer	5R01CA258231-04	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Wen, Kuang-Yi	Thomas Jefferson University United States	A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors	5R01CA222246-05
Wheeler, Stephanie Brooke	Univ Of North Carolina Chapel Hill United States	Optimizing Endocrine Therapy Adherence through Motivational Interviewing and Text Interventions	5R01CA237357-05	PA-18-004 (R01 Clinical Trial Optional)
Whitman, Eric	Atlantic Health System, Inc. United States	The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)	5UG1CA239772-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Wilkin, Timothy J	Weill Medical Coll Of Cornell Univ United States	Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico	5U54CA242639-05		Silvina Frech, Ph.D., M.S.
Wilkin, Timothy J	Weill Medical Coll Of Cornell Univ United States	Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)	5UG1CA275414-02		Silvina Frech, Ph.D., M.S.
Williams, Paige L	Harvard School Of Public Health United States	Pediatric HIV/AIDS Cohort Study (PHACS) 2020	5P01HD103133-04
Wilson, Michael R	Wayne State University United States	Does obesity influence protein quality control in endometrial cancer?	5R00CA252152-04
Winer, Rachel L.	University Of Washington United States	The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base	5UG1CA275402-02		Silvina Frech, Ph.D., M.S.
Winters-Stone, Kerri M	Oregon Health & Science University United States	Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer	5R01CA248059-04		Goli Samimi, Ph.D., M.P.H.
Wolpin, Brian Matthew	Dana-Farber Cancer Inst United States	Altered metabolism and machine learning for pancreatic cancer early detection	5U01CA210171-07	PAR-21-334 (U01 Clinical Trial Optional)
Wu, Yun	State University Of New York At Buffalo United States	Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay	5R01CA272827-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Wu, Yun	State University Of New York At Buffalo United States	Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection	5R21CA267934-02	PAR-20-292 (R21 Clinical Trial Optional)
Wu, Bechien	Kaiser Foundation Research Institute United States	PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (PRO-TECT)	5R01CA230442-05
Wu, Xiangwei	University Of Tx Md Anderson Can Ctr United States	Activating p53 for colorectal cancer prevention	5R01CA214954-06
Xiao, Yi	University Of Tx Md Anderson Can Ctr United States	Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1	1R21CA286318-01		Anda Vlad, M.D., Ph.D.
Xing, Chengguo	University Of Florida United States	Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation	5R03CA273467-02
Yaddanapudi, Kavitha	University Of Louisville United States	A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer	5R21CA277314-02	PAR-20-292 (R21 Clinical Trial Optional)
Yaghjyan, Lusine	University Of Florida United States	Stromal contributions to breast carcinogenesis	1R01CA277817-01A1		Christos Patriotis, Ph.D., M.Sc.
Yang, Wan	Columbia University Health Sciences United States	UNCOVER: underlying novel causes of onset of very early cancer research	5R01CA257971-03		Nick Hodges, Ph.D.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future	5R01CA227576-05		Eileen Dimond, R.N., M.S.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care	5R01CA261874-02		Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna	Roswell Park Cancer Institute Corp United States	Metformin for chemoprevention of lung cancer in obese subjects at high risk	3R01CA255515-03S1
Yennu, Sriram	University Of Tx Md Anderson Can Ctr United States	Opioid-Sparing Interdisciplinary Interventions Addressing Pain in Head and Neck Cancer Patients	5R21CA252446-02		Rachel Altshuler, Ph.D.
Yennu, Sriram	University Of Tx Md Anderson Can Ctr United States	A Combination Therapy to Treat Cancer-Related Fatigue	5R01CA231521-05
Yost, Kathleen J	Spectrum Health Hospitals United States	Cancer Research Consortium of West Michigan (CRCWM)	5UG1CA189860-10
You, Ming	Methodist Hospital Research Institute United States	Chemoprevention of lung cancer by targeting lonidamine to mitochondria	5R01CA232433-05
You, Ming	Methodist Hospital Research Institute United States	Inhibition of Oral Tumorigenesis by Antitumor B	7R01CA205633-06		Eva Szabo, M.D.
You, Ming	Methodist Hospital Research Institute United States	Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis	1R01CA280746-01A1		John Clifford, Ph.D.
You, Ming	Methodist Hospital Research Institute United States	Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer	5R01CA223804-05
Yu, Anthony Francis	Sloan-Kettering Inst Can Research United States	Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-based Chemotherapy	5R03CA277194-02		Eileen Dimond, R.N., M.S.
Yu, Dihua	University Of Tx Md Anderson Can Ctr United States	Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer	5R01CA270010-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Yu, Danxia	Vanderbilt University Medical Center United States	Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery	1R01CA275864-01A1		Edward Sauter, M.D., Ph.D.
Yu, Anthony Francis	Sloan-Kettering Inst Can Research United States	Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial	1R37CA273923-01A1		Eileen Dimond, R.N., M.S.
Yuan, Ying	University Of Tx Md Anderson Can Ctr United States	Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions	5U24CA274212-02	RFA-CA-21-055 (U24 Clinical Trial Not Allowed)
Zarrinpar, Amir	University Of California, San Diego United States	Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer	5U01CA265719-03
Zeng, Melody Yue	Weill Medical Coll Of Cornell Univ United States	Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis	5R21CA270998-02
Zhang, Fan	University Of Florida United States	R21 MPI microRNA directed therapy for treating early stage pancreatic cancer	5R21CA277263-02
Zhang, Zhen	Johns Hopkins University United States	A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach	5U2CCA271891-02		Christos Patriotis, Ph.D., M.Sc.
Zhao, Hua	University Of Virginia United States	Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor	7U01CA260731-02	PAR-18-913 (U01 Clinical Trial Not Allowed)
Zheng, Yingye	Fred Hutchinson Cancer Center United States	Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit	1U24CA288185-01		Christos Patriotis, Ph.D., M.Sc.
Zheng, Yingye	Fred Hutchinson Cancer Center United States	Statistical Methods for Prospective Evaluation of Biomarkers	5R01CA236558-14		Nick Hodges, Ph.D.
Zhou, Xianghong Jasmine	University Of California Los Angeles United States	Detecting and locating cancer for patients with CT-detected lung nodules	5R01CA264864-02	PAR-19-264 (R01 Clinical Trial Optional)
Zhou, Xianghong Jasmine	University Of California Los Angeles United States	Multi-cancer early detection using cell-free DNA methylome analysis	1U01CA285010-01
Zhou, Chuan	University Of Michigan At Ann Arbor United States	Histopathology correlated quantitative analysis of lung nodules with LDCT for early detection of lung cancer	5U01CA216459-05	PAR-16-089 (U01)	Guillermo Marquez, Ph.D.
Zhou, Xianghong Jasmine	University Of California Los Angeles United States	The UCLA Center in Early Detection of Liver Cancer	2U01CA230705-06
Zhu, Yazhen	University Of California Los Angeles United States	Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles	1R01CA277530-01A1
Zhu, Yazhen	University Of California Los Angeles United States	Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma	5R01CA255727-04

Funded Grants

FOLLOW US AT:

POLICIES

NCI'S PDQ® EVIDENCE-BASED SUMMARIES

GENERAL INFORMATION